Cargando…
Patient Perspectives on Factors Affecting Direct Oral Anticoagulant Use for Stroke Prevention in Atrial Fibrillation
INTRODUCTION: Oral anticoagulant therapy choices for patients with atrial fibrillation (AF) expanded in the last decade with the introduction of direct oral anticoagulants (DOAC). However, the implementation of DOACs was slow and varied across different health economies in England. There is limited...
Autores principales: | Medlinskiene, Kristina, Richardson, Susan, Fylan, Beth, Stirling, Katherine, Rattray, Marcus, Petty, Duncan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121672/ https://www.ncbi.nlm.nih.gov/pubmed/34007161 http://dx.doi.org/10.2147/PPA.S302016 |
Ejemplares similares
-
Barriers and enablers to healthcare system uptake of direct oral anticoagulants for stroke prevention in atrial fibrillation: a qualitative interview study with healthcare professionals and policy makers in England
por: Medlinskiene, Kristina, et al.
Publicado: (2023) -
Barriers and facilitators to the uptake of new medicines into clinical practice: a systematic review
por: Medlinskiene, Kristina, et al.
Publicado: (2021) -
Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022) -
Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
por: Duong, Eric, et al.
Publicado: (2023) -
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)